Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-052397

Chief Financial Officer sold 10,000 shares at an average $66.23 ($662,299)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GARCIA PETER S · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-17 Exercise or conversion : show line 1 in the form +10,000 $4.08 $40,800 19,331 D
2021-08-17 Sale : show line 2 in the form −4,687 $65.24 $305,757 14,644 D
2021-08-17 Sale : show line 3 in the form −2,368 $65.83 $155,892 12,276 D
2021-08-17 Sale : show line 4 in the form −505 $67.13 $33,899 11,771 D
2021-08-17 Sale : show line 5 in the form −2,400 $68.34 $164,005 9,371 D
2021-08-17 Sale : show line 6 in the form −40 $68.62 $2,745 9,331 D
Open-market sales · 10,000 sh · avg $66.23 · $662,299

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-17 Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) −10,000 136,289 D
Loading xslF345X03/doc4.xml…